Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gynecology

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 36 articles:
HTML format
Text format



Single Articles


    August 2017
  1. PIGNATA S, Scambia G, Bologna A, Signoriello S, et al
    Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study.
    J Clin Oncol. 2017 Aug 21:JCO2017734293. doi: 10.1200/JCO.2017.73.4293.
    PubMed     Text format     Abstract available


  2. OTT PA, Bang YJ, Berton-Rigaud D, Elez E, et al
    Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study.
    J Clin Oncol. 2017;35:2535-2541.
    PubMed     Text format     Abstract available


    July 2017
  3. SAMIMI G, Bernardini MQ, Brody LC, Caga-Anan CF, et al
    Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.
    J Clin Oncol. 2017;35:2329-2337.
    PubMed     Text format     Abstract available


  4. WILLMANN JK, Bonomo L, Carla Testa A, Rinaldi P, et al
    Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results.
    J Clin Oncol. 2017;35:2133-2140.
    PubMed     Text format     Abstract available


    June 2017
  5. SMITH SG, Sestak I, Howell A, Forbes J, et al
    Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I).
    J Clin Oncol. 2017 Jun 29:JCO2016717439. doi: 10.1200/JCO.2016.71.7439.
    PubMed     Text format     Abstract available


    May 2017
  6. HOFFMAN RM, Lo M, Clark JA, Albertsen PC, et al
    Treatment Decision Regret Among Long-Term Survivors of Localized Prostate Cancer: Results From the Prostate Cancer Outcomes Study.
    J Clin Oncol. 2017 May 11:JCO2016706317. doi: 10.1200/JCO.2016.70.6317.
    PubMed     Text format     Abstract available


    April 2017
  7. CHRISTIE EL, Fereday S, Doig K, Pattnaik S, et al
    Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer.
    J Clin Oncol. 2017;35:1274-1280.
    PubMed     Text format     Abstract available


  8. SHAIKH F, Cullen JW, Olson TA, Pashankar F, et al
    Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group.
    J Clin Oncol. 2017;35:1203-1210.
    PubMed     Text format     Abstract available


  9. LHEUREUX S, Bruce JP, Burnier JV, Karakasis K, et al
    Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition.
    J Clin Oncol. 2017;35:1240-1249.
    PubMed     Text format     Abstract available


  10. LUO J, Chlebowski RT, Hendryx M, Rohan T, et al
    Intentional Weight Loss and Endometrial Cancer Risk.
    J Clin Oncol. 2017;35:1189-1193.
    PubMed     Text format     Abstract available


  11. TAYLOR JS, Rajan SS, Zhang N, Meyer LA, et al
    End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer.
    J Clin Oncol. 2017 Apr 7:JCO2016702894. doi: 10.1200/JCO.2016.70.2894.
    PubMed     Text format     Abstract available


  12. GERSHENSON DM, Bodurka DC, Coleman RL, Lu KH, et al
    Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum.
    J Clin Oncol. 2017;35:1103-1111.
    PubMed     Text format     Abstract available


  13. MOORE KN, Martin LP, O'Malley DM, Matulonis UA, et al
    Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study.
    J Clin Oncol. 2017;35:1112-1118.
    PubMed     Text format     Abstract available


    February 2017
  14. HUMMEL SB, van Lankveld JJ, Oldenburg HS, Hahn DE, et al
    Efficacy of Internet-Based Cognitive Behavioral Therapy in Improving Sexual Functioning of Breast Cancer Survivors: Results of a Randomized Controlled Trial.
    J Clin Oncol. 2017 Feb 27:JCO2016696021. doi: 10.1200/JCO.2016.69.6021.
    PubMed     Text format     Abstract available


  15. ROSENTHAL AN, Fraser LS, Philpott S, Manchanda R, et al
    Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
    J Clin Oncol. 2017 Feb 27:JCO2016699330. doi: 10.1200/JCO.2016.69.9330.
    PubMed     Text format     Abstract available


    December 2016
  16. RUTTEN MJ, van Meurs HS, van de Vrie R, Gaarenstroom KN, et al
    Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial.
    J Clin Oncol. 2016 Dec 28:JCO2016692962.
    PubMed     Text format     Abstract available


  17. LIU JF, Ray-Coquard I, Selle F, Poveda AM, et al
    Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer.
    J Clin Oncol. 2016;34:4345-4353.
    PubMed     Text format     Abstract available


  18. LEIJEN S, van Geel RM, Sonke GS, de Jong D, et al
    Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 Months.
    J Clin Oncol. 2016;34:4354-4361.
    PubMed     Text format     Abstract available


    August 2016
  19. WRIGHT AA, Bohlke K, Armstrong DK, Bookman MA, et al
    Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
    J Clin Oncol. 2016 Aug 8. pii: JCO686907.
    PubMed     Text format     Abstract available


    June 2016
  20. WENTZENSEN N, Poole EM, Trabert B, White E, et al
    Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.
    J Clin Oncol. 2016 Jun 20. pii: JCO668178.
    PubMed     Text format     Abstract available


  21. KURZEDER C, Bover I, Marme F, Rau J, et al
    Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE).
    J Clin Oncol. 2016 Jun 6. pii: JCO660787.
    PubMed     Text format     Abstract available


    May 2016
  22. DEMEESTERE I, Brice P, Peccatori FA, Kentos A, et al
    No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.
    J Clin Oncol. 2016 May 23. pii: JCO658864.
    PubMed     Text format     Abstract available


    April 2016
  23. WRIGHT JD, Burke WM, Tergas AI, Hou JY, et al
    Comparative Effectiveness of Minimally Invasive Hysterectomy for Endometrial Cancer.
    J Clin Oncol. 2016;34:1087-96.
    PubMed     Text format     Abstract available


    March 2016
  24. VERGOTE I, Armstrong D, Scambia G, Teneriello M, et al
    A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess Efficacy and Safety of Weekly Farletuzumab in Combination With Carboplatin and Taxane in Patients With Ovarian Cancer in First Platinum-Sensitive Relapse.
    J Clin Oncol. 2016 Mar 21. pii: JCO632596.
    PubMed     Text format     Abstract available


  25. WRIGHT AA, Cronin A, O'Malley DM
    Reply to G.B. Holt.
    J Clin Oncol. 2016;34:1016-7.
    PubMed     Text format    


  26. TUNG N, Lin NU, Kidd J, Allen BA, et al
    Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.
    J Clin Oncol. 2016 Mar 14. pii: JCO650747.
    PubMed     Text format     Abstract available


  27. CHAN JK, Monk BJ
    Reply to F.M. Muggia.
    J Clin Oncol. 2016;34:882-3.
    PubMed     Text format    


  28. BOOKMAN MA, Brady MF
    Reply to F.M. Muggia.
    J Clin Oncol. 2016;34:884.
    PubMed     Text format    


  29. SCHRADER KA, Stratton KL, Murali R, Laitman Y, et al
    Genome Sequencing of Multiple Primary Tumors Reveals a Novel PALB2 Variant.
    J Clin Oncol. 2016;34:e61-7.
    PubMed     Text format    


    February 2016
  30. LOPES LF, Macedo CR, Aguiar Sdos S, Barreto JH, et al
    Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
    J Clin Oncol. 2016;34:603-10.
    PubMed     Text format     Abstract available


  31. LAMM W, Schiefer A, Nobauer IM, Horvat R, et al
    Aromatase Inhibitor Therapy As Effective Rescue in a Patient With Tamoxifen-Refractory Metastatic Granulosa Cell Tumor of the Ovary.
    J Clin Oncol. 2016;34:e31-3.
    PubMed     Text format    


  32. MUGGIA FM
    Intraperitoneal Therapy for Ovarian Cancer.
    J Clin Oncol. 2016 Feb 1. pii: JCO628370.
    PubMed     Text format    


    January 2016
  33. BOULAY RM
    Beautiful Imperfections.
    J Clin Oncol. 2016;34:286-7.
    PubMed     Text format    


  34. PUJADE-LAURAINE E, Selle F, Weber B, Ray-Coquard IL, et al
    Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study.
    J Clin Oncol. 2016 Jan 11. pii: JCO621474.
    PubMed     Text format     Abstract available


  35. HOLT GB
    Potential Simpson's Paradox in Multicenter Study of Intraperitoneal Chemotherapy for Ovarian Cancer.
    J Clin Oncol. 2016 Jan 11. pii: JCO644542.
    PubMed     Text format    


    December 2015
  36. RUNOWICZ CD, Leach CR, Henry NL, Henry KS, et al
    American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.
    J Clin Oncol. 2015 Dec 7. pii: JCO.2015.64.3809.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: